XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurement
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurement
The following tables summarize the valuation of the Company’s Level I financial assets and liabilities that fall within the fair value hierarchy (in thousands):
March 31, 2023December 31, 2022
Assets
Equity method investments - fair value option$38,281 $20,907 
Equity investments9,785 12,072 
Total assets$48,066 $32,979 
Liabilities
Liabilities of consolidated Public SPACs:
Public warrants$1,417 $667 
Total liabilities$1,417 $667 
As of March 31, 2023 and December 31, 2022, the Company did not hold any Level II or Level III financial instruments. The valuation methodology used in the determination of the changes in fair value of financial instruments for which Level III inputs were used at March 31, 2022 included a combination of the market approach and income approach.
The following tables summarize the changes in the fair value of financial instruments for which the Company has used Level III inputs to determine fair value (in thousands):
Three Months Ended March 31,
20232022
Derivative liabilities
Balance, beginning of period$ $1,386 
Unrealized losses, net 1,025 
Balance, end of period$ $2,411 
Total realized and unrealized gains and losses recorded for Level III investments are reported in unrealized gains (losses) on derivative liabilities of Public SPACs in the Condensed Consolidated Statements of Operations.